App Store Rejection

Avoiding app store rejection – the importance of using a medical app development specialist

There are many risks associated with using an app development agency that doesn’t specialise in developing medical apps but the most common one is app store rejection. Read on.

Over the past few years we’ve been approached by a few companies that have embarked on an app development project with a different agency only to find out that at the end of the development process they’ve have been unable to get their newly developed medical app published onto the app store.

They’ve approached us for help, because more often than not the main reason why their app has been rejected is because it does not conform to the regulatory guidelines that have been set for publishing medical apps. If you’re developing an app that is going to be classed as a medical device, then Apple will need to see evidence that you’ve compiled the appropriate paperwork required for launching an app of that nature onto the market. This will often include a genuine copy of the CE Mark certificate that only gets issued to the manufacturer of the device once all the required paperwork has been submitted to the appropriate competent authority within your country, like the MHRA in the UK.

Apple released their expanded section focused on safety requirements for health and medical apps back in 2016, so we get a little surprised when we get requests for help from companies who have had their app rejected due to regulatory issues.

Under the “Physical Harm” section, the guidelines provide several examples of user risk issues that may lead to rejection of an app.

  • For instance, medical apps intended for diagnosis or treatment or that run the risk of generating inaccurate health data “may” undergo more vigorous review by Apple; apps that have received regulatory clearance should provide links to appropriate documentation, as well
  • If your medical app has received regulatory clearance, please submit a link to that documentation with your app.
  • Drug dosage calculators must come from the drug manufacturer, a hospital, university, health insurance company, pharmacy or other approved entity, or receive approval by the FDA or one of its international counterparts. Given the potential harm to patients, we need to be sure that the app will be supported and updated over the long term.

If you’re looking to develop a medical device app then it’s vital that you do the required regulatory research and due-diligence on the app development companies that are being considered for your project. Ask them to show you apps that they have developed which carry the CE Mark (all apps that are classed as medical devices need to have a page within the app itself where the CE Mark is displayed).

You’ll need to consider the classification of your device as the guidelines differ for the various regulatory classes as well as the software safety class, while making sure your organisation can meet all of those guidelines.

At the end of the day the guidelines are there to protect patients and healthcare professionals that will be using your app and if you or your chosen app developer doesn’t have the required expertise to not only code these types of apps but to also produce the appropriate compliance paperwork for submission, then you will end up facing the same scenario above, which could prove very costly.

If your app meets the definition of a medial device then you could also face a significant fine for a regulatory violation, from the competent authority responsible for the registration of medical devices. Developing mobile applications that function as medical devices is complex. Choosing the right partner is more than just about assessing their technical capability. Medical device app developers also need to understand the regulatory and security requirements, so make sure you do the right research before choosing your app development partner.

To learn more about our expertise and experience in developing medical device apps, check out our portfolio and our medical device app development section on our website. Alternatively get in touch.

Tips for designing a medical device

Tips for designing a medical device – is connectivity on your list?

I came across an interesting discussion on LinkedIn titled: “One tip for designing a medical device.”
Members of one of the medical device groups were being asked to share their views on what advice they would give someone when it came to designing a medical device?

The post as you can imagine got a great deal of response (the group currently has over 320,000 members). I read through the responses with interest and although all the responses were well considered. Some of the advice shared was:

“I would recommend co-development of the product with the customer. This provides clear understanding by both parties of what the design requirements are, what testing is required, expected costs, lead times, design for manufacturability issues, and mostly, you have the most important thing, at least one customer.”
“In my past we were successful by starting a voice of customer assessment and convert that into a list of customer requirements. Then have R&D translate that into functional spec of what they could provide and on top of that what other features or capabilities that customers are not aware of. Then a negotiation occurs where there are mismatches and confirmed with customers. In parallel how will it be verified and validated, sample availability, collaborations needed? Then and only then do we start development.
“Ask the customer exactly what they need and why, what are the features they could not do without? Would this new product get then to move away from what they already use, and why, why not? ensure they get just that… and quickly. Then ensure their experience is backed up with service.”

“Most of the time customers, don’t really know very clearly what their needs are, especially physicians. But patients, caregivers probably understand better way what can help them and what they are willing to pay for it. Latin America still needs help in rural medicine: handle chronic disease, early diagnosis especially in oncology. I agree about co-development.

As you can expect with any conversation around new product development there is this recurring theme of start with the end-user. And this is all sound advice and as a marketer this notion that the customers’ needs drive the NPD process is etched into my brain. But it also got me thinking that when it comes to medical devices we should also be considering how we can take advantage of new technological advances taking place and look for opportunities to future-proof any device that we are looking to design. This will help to increase the product’s shelf-life as well as improve the product’s chances of generating a healthy return on investment. But as we know technology is moving faster than ever so this becomes and an even greater challenge for medical device manufacturers.

One area that can sometimes get missed during the initial concept and business analysis phases is “connectivity” – so assessing the capacity for the interconnection of platforms, systems, and applications. I would most certainly be bringing connectivity to the table early on in the process and exploring how mobile technologies could help to improve the user experience and also the cost effectiveness of developing such a device. Let me share some of the benefits that we’ve witnessed through our involvement in developing apps for connected medical devices and designing CE Marked mobile applications for the healthcare sector.

Improving end-user experience

  1. Control interfaces: OvuSense streamlines the user experience taking advantage of high res screens with more real estate to graphically monitor temperatures and get fertility predictions compared the original black and white LCD screen on the original hardware product
  2. Portability and access: Rosemont Pharma changed a very large ring bound folder which references their entire product range and has consolidated all the information into an online database which is updated to an app every time the app is opened and fits in the pocket.
  3. On Demand: Dr Now / Push Doctor, these types of on demand apps are the future of medical services. Real time access to medical professionals when required with minimum disruption to your own schedule.
  4. Data sharing and analysis: Diabetes apps like enable patients to accurately monitor their blood sugar levels and at the same time automatically share this data with healthcare professionals who can monitor their patients remotely and intervene if necessary.

Cost of development

  1. Less investment in hardware: Fertility Focus have moved away from the physical production of a hardware reader to an app that utilises the hardware within a device. This massively reduces the investment in manufacturing and enable a constant evolution of the product features
  2. Concept testing / rapid prototyping: The Instant Weight For Height calculator was prototyped and tested by healthcare professionals to make sure it was easy to use and complex calculations would be simple to interpret before going to the coding stage. This allowed for a much quicker development cycle having ironed out any design issues before hand
  3. Updating firmware: Fitbit is a good example of where the product software or firmware is constantly evolving to incorporate customer feedback and improve user experience. Distribution is over the air via an app update which in turn updates the firmware on the wrist band.
  4. Distribution: The distribution and update of apps has become a seamless process with both Apple and Android devices performing automatic updates for the apps running on their devices. This massively improves reliability of the apps, the devices and is a simple push to an app store that then distributes the apps to millions of devices.
Visit us on stand 27 at MedTech Expo

Visit us on stand 27 at MedTech Innovation Expo

Genetic Digital - MedTech Innovation Expo
Genetic Digital
are going to be exhibiting at this year’s MedTech Innovation Expo at the Ricoh Arena, Coventry on the 20th & 21st April.

As specialists in developing web and mobile solutions for the healthcare, pharma and medical device sectors this will give attendees a great opportunity to come and talk to us and learn more about the mobile apps we have built for our clients.

We’ve developed apps that interface with medical devices; taken apps through CE Marking and built sophisticated online ordering systems.

Win an Apple WatchWe will also be giving you the opportunity to test our demo app which connects to a medical device and by doing so you’ll also be entered into our prize draw to win an Apple_Watch_official_logo.sMALL.fw.

Terms & Conditions Apply

Visit us on stand #27 or arrange a meeting with us in advance.

Text Messaging

Can Text Messaging Improve Patient Engagement Outcomes?

Text messagesMedication non adherence is a significant problem, it always has been and it will continue to be so with an estimated cost to the NHS of £600m* a year! So what can be done to improve patient outcomes? Changing patient behaviour is key to this and there have been a number of clinically led studies conducted that demonstrate that apps can help to improve compliance.  But, when looking at patient engagement, perhaps there is another solution where a person-centric approach is more likely to improve the odds of success. A successful engagement programme needs healthcare providers to be able to reach their patients in familiar and effective ways and by doing this, patients are encouraged to take an active role in their treatment which will in turn lead to better healthcare outcomes.

This is where I think text messaging could be the answer.

It’s a cost effective way of providing a more personalised experience with a greater reach than just smartphone users. Last year over 145 billion* text messages were sent and despite the rise of instant messaging platforms among younger users, text messages remain device agnostic and one of the easiest ways reach anyone with a mobile phone.

The Personal Touch

Your health is a private matter and the more personalised the experience, the more likely patients are to respond and take an active role in managing their own treatment. Medication reminders, exercise reminders, appointment booking, pre-op instructions, post op advise can all be communicated ‘one-on-one’ and doing this on a personal level, knowing that a real person is supporting them, can be a real motivator to empowering them to make the necessary changes.

A GSMA study in 2012 showed that 54% of consumers wanted to improve their healthcare using their mobiles in more personalised ways, taking more control in their treatment.

Patient Preferences


In order for any patient engagement programme to be successful the number of patients you are able to reach is very important. Patients comes from a variety of backgrounds and demographics with a range of communication preferences. Combined with the fact that it’s not always possible to be connected to the internet, text messaging offers the lowest common denominator and most reliable way of contacting patients. Text messaging also is the quickest way to reach the most people. The average text message is read within the first 90 seconds, whereas the average email is opened within the first 90 minutes*.


Clearly security and compliance are also considerations for any healthcare system that communicates patient information. The text messages can be stored securely inline with HIPAA compliance but because security depends on the cooperation of all parties involved in the transmission process there are bound to be challenges. However if the tool is used correctly, with guidelines in place to support patients with their treatment plans and not for discussing medical issues, many of these security concerns are negated.


There is no doubt that apps and smartphones will make communication easier, reduce costs and improve efficiencies throughout the NHS. But let’s not just assume that apps are the answer before considering all the technologies available to us and the way in which patients use them. Familiarity, reach and simplicity can play a big role in the success of an initiative like this and, used in the correct way, could see tangible benefits in terms of outcomes and cost savings.

Image credit: Amancay Maahs (

Connecting your medical app or website to the NHS : The N3 Network

Many ideas for apps and websites we deal with are based around some interaction with the NHS but integrating with NHS services and facilities isn’t always straight forward. One of the barriers to entry is the NHS N3 network. N3 is the broadband network for the NHS which connects all NHS locations and over a million employees. It connects hospitals, GP surgeries, pharmacies and many other service providers to securely facilitate sharing of healthcare data including sensitive patient records.

If your app, website or service needs to interact with NHS data then you may well need to be connected to the N3 network. As specialist providers of health related apps and websites, Genetic Digital’s customers often fall in to this category with web services we develop (which are often the backend of an app) requiring access. However, just to muddy the waters somewhat, N3 connectivity isn’t always mandatory (which can be true for non Patient Identifiable Data only); some NHS trusts have a more relaxed approach than others depending on their internal IT policies and configuration.

So who needs an N3 connection? There are no hard and fast rules but, broadly speaking, if you want to exchange data with an NHS trust (or trusts), especially sensitive data such as patient records, then you’ll need to be on N3. Even if it’s not a requirement if you are offering an on-premise solution, it’s often a commercial advantage if you can offer it. Given two competing services, an NHS trust could well choose one that offers services via N3 over one that doesn’t.

One point worth noting is only traffic from England can flow over the N3 connection so you can’t manage the service from an Indian call centre for example or push or pull patient data from Scotland, Wales or any other country. Knowing where your data resides is vital in applying for your accreditation to connect to N3.

How do you go about connecting to the N3 network? It’s a multi-step process with the first being deciding who you will contact to request access. For this, there are two options, one is to deal with the HSCIC direct (the N3 service provider) and the other is to deal with an N3 commercial aggregator. Dealing direct the process tends to take longer and commercial aggregators are organisations who have been granted power by the HSCIC to vet, assess and grant end user access requests to N3. This latter route is often much quicker and enables you to work with experienced staff who can offer direct support to help complete the required documentation.

Once a request is made there are then two parts of a pre-assessment questionnaire that need completing:

  • The HIGCAP – an eight question form asking about the nature of the connection, name of the company making the request, contact details, ISO certification status etc.
  • You then need to get a sponsor to complete their portion of the form – a sponsor is a responsible individual within an NHS organisation who will vouch for your connection application, for example, a senior manager with knowledge of your project.

After the above two are completed they are assessed for pre-approval. Once pre-approved you move on to:

  • The LCA – Local Connection Architecture questionnaire – this is a comprehensive break down of why the N3 is required – what the connection is for, the type of data etc.

If using a commercial aggregator, a meeting or conference call is usually had to discuss the LCA and help complete it. Once completed to the satisfaction of the provider, N3 approval is granted and a connection is setup.

Once an N3 connection is setup, the end user (our client for example) is obliged to complete the IG Toolkit. This is a process similar to ISO27001 certification which ensures procedures and policies are in place to prevent misuse or negligence of the N3 connection and associated service. They have until the end of March to complete it, so, if access is granted on the 30th March they have 1 day to complete it, if access is granted on 1st April they have a full year. Yes, this is odd. Because of this, completion is not strictly enforced and can (and does) take longer to complete. However, ultimately it needs to be done annually.

What type of connection would I need? For our customers, the need is most often for hosting a server which can connect to N3. Commercial aggregators such as Redcentric own their own data centres with a direct connection to the N3 backbone.  Once approved, our clients can host their servers, either physical or virtual cloud based, in the data centre and their app or web visitor traffic flows in over the public internet and out over the N3. To ensure integrity of the N3 service, you are obliged to utilise a managed firewall that monitors and filters all traffic that crosses over the N3 boundary.

If your service is connected outside of a data centre, in a pharmacy for example, then, in addition to the N3 connection and firewall, you would need to purchase a broadband connection from the commercial aggregator at rates comparable to standard DSL providers.

What about the costs? There are no direct costs associated with obtaining an N3 connection but, like all network connections, there are ongoing costs for using it. There is a minimum 3 year contract and costs increase depending on the speed required. Connections are sold in increments of 1Mb/s which, despite sounding slow (a domestic high speed broadband connection is upwards of 50Mb/s), when dealing with low traffic levels and small packets of text data often used in apps, the basic 1Mb/s can sometimes suffice. Additionally, there are costs for the firewall, hosting in the data centre if necessary and costs for an external DSL connection if required. In all likelihood there would also be consultancy costs associated with completing the IG Toolkit.

In summary, there are commercial benefits to having an N3 connection available to your service and in many instances it will be a necessity. But it comes at a price, both financial and administrative so the decision to apply shouldn’t be taken lightly and should be based on your specific needs, requirements and business opportunities.

Thanks to Redcentric for their expert N3 knowledge that helped shape this article.

To find out more about how Genetic Digital’s expertise in building and marketing healthcare and pharmaceutical websites and apps could benefit your project contact us now.

Medical apps on a tablet

EU to adopt a Green Paper on mobile health

Today, a Green Paper on mobile health (mHealth) will be published by the European Commission. mHealth covers all medical and public health practice that is supported by mobile devices. This document will launch a community discussion process that will continue until 2 July 2014.

Covering all practice supported by mobile devices – including tablets, smartphones, and other wireless devices mHealth also includes wellbeing and lifestyle apps that connect to sensors and other medical devices. This is an important and emergent part of eHealth where Information as well as Communication Technology is used to improve services, processes and health products.

The Commission will be looking at several issues surrounding mHealth:

  • Data protection
  • Patient safety
  • Users trust
  • Input to the delivery of healthcare of the highest quality
  • The level at which this should be applied e.g. – national, regional, or EU wide.

As well as the Green Paper, European Commission direction will also be given through a Staff Working Document, to those involved in app development. This will analyse existing EU legal frameworks currently applicable that are applicable to wellbeing and to lifestyle apps.

There is no doubt that mHealth can help to tackle some of the challenges that our healthcare structure faces. And according to a report by PWC mHealth could potentially deliver €99 billion in care costs by 2017. It is a fast evolving field with the potential to improve healthcare quality and improve efficiency by offering support to professionals in healthcare and in the area of patient treatment. It will also facilitate continuity of care. Some estimates show that as much as 30% of time spent accessing or analysing information could be saved if medical professionals used mHelath-based technology. Remote monitoring facilities could help many more patients live independently supported by technological monitoring systems. Despite this potential, the uptake of mHealth, at present, remains restricted in EU countries and healthcare authorities may look for more confirming evidence before they are prepared to adopt mHealth more comprehensively.

Some criticisms have been:

  • Lack of observance and transparency might make users wary of placing their trust in these apps, which may impact on market development.
  • Insufficient knowledge among developers with regard to the legalities applicable to lifestyle and well-being apps.

It is hoped that the Staff Working Document being issued with the Green Paper, will raise awareness amongst app developers of the rules being imposed by the EU surrounding issues of data protection, and will assist them in determining whether the legislation is applicable to their app, or not. It will also issue consumer directives.
At Genetic Digital we have been in the vanguard of this new technology and we were asked, as trail blazers in this field to take part in an interview on the subject being covered by BBC News.

Some of the areas of concern have been:

  1. How mHealth can be aligned with national health care strategies
  2. Technology/Interoperability standards
  3. Data protection and security
  4. Regulation and compliance keeping pace with development
  5. Getting patients and HCP involved earlier during solutions
  6. Lack of evidence of economic or clinical benefit – (it is worth noting that before email became widespread Intel surveys showed that most people claimed not to want it.)

The era of mHealth has arrived.

Stage 1
At this first stage consumer friendly products link fitness to general wellbeing as seen with Jawbone/Fitbit.

Stage 2
Apps and mobile connected devices permeate the medical field (we have entered this stage)

Stage 3
Mobile, wearables & data-collection devices mesh together to provide the backbone for optimisation & customisation of preventative health, medical treatment & hospital processes.

This is new and exciting technology and the release of the Green Paper is a step to its validation. In years to come will we wonder, as we do now with email technology, how we ever managed without it?

View the Green Paper

If you’d like to respond to the paper visit the EU website where the paper is published

How apps could help to improve medication adherence

Playing Games With Your Medicine

The stampede towards campaigns on social media and mobile apps designed to increase health awareness, continues.  The same media is also being used to promote patient adherence to medication regimes.  Some of the most inventive ways being employed to get patients involved have been with the use of gaming apps.  Inelegantly labelled SMAG’s which stands for Social, mobile and games, the technology is still very much a new innovation and the question is – are they just a gimmick or will they really do anything to help the adherence to medication in those that they are aimed at?

There is no doubt that medication adherence is now a multi billion dollar per year problem, and one of those working on using gaming to address the problem is Mango who have observed that the industry has tended to focus on two main areas.  The first is tracking the consumption of medicine by patients.  The second area of focus has been analysis of patient data to better identify the populations at risk in various scenarios.  However, it is now thought that the root cause of patient non adherence is likely to be due more to behavioural issues.

mango drug adherence app

With the app that Mango produce the patient can enter any supplements or medication that they need to take as well as the timing and the dosage of that medication.  The app, that is typical of the many adherence apps on the market, will advise patients of the time that they need to take their medication.  It will also alert the user to any potential reaction between medications that might prove dangerous.   But it is the gaming side that the makers are hoping will give their app the edge.  The game involves a currency that is unique to the game and the user will ‘earn’ the virtual money by being rewarded for taking medication on time, for instance.  There is a levelling up scheme that means that the users of the gaming system of adherence can progress to actual rewards from Mango’s partners. The type of rewards on offer will include items such as donations to charities and rewards that can be redeemed at retailers.  Another interesting feature of the gaming app is that the user can see how their adherence to medication compares with others suffering from the same condition. The Mango app is aimed at middle aged people diagnosed with certain conditions although in practice the makers have found that they have had users in their twenties as well as in their seventies.  Maybe it never is too late to teach an old or a young dog new tricks!

Clinical pathway apps

Turning your clinical pathway into a mobile app

It has been reported that health and wellbeing applications are estimated to make up approximately 40% of new smartphone apps currently being developed. Health and medical related apps have the potential to be adapted and used by healthcare professionals, helping to revolutionise the sector and reflect the digital age we live in.

There has also been a lot of discussion around providing HCPs with greater access to clinical pathways and care maps so that they can easily check medical guidelines on the go to help ensure that they are implementing a specific task in-line with best practice.

So, does it make sense for healthcare organisations to create handy mobile apps that HCPs can quickly and easily access on their smartphone so that they can check to make sure that they’re following the correct procedure?

Here are 5 key areas for you to consider that will help you to make an informed decision.

1. Does the pathway already exist already?
Because clinical pathways exist to promote efficient patient care based on evidence based practice they are more often than not available in a paper format but trying to track them down can be difficult. If the pathway already exists in paper based format then it’s more than likely that the pathway can be re-produced to work as an app, providing that there is a clear process that can be followed.

2. Can the pathway be used in its current format or does it need modifying?
Generally clinical pathways refer to medical guidelines. However a single pathway may refer to guidelines on several topics in a well specified context, for example both paediatric and adult pathways for a single indication, so it’s important to imagine the user and the point at which they may need to engage with the pathway. If the pathway is overly complex covering a number of topics, can it be reproduced in a number of different flavours making it easier for the end user to access the correct pathway more quickly?

3. Additional help information and any other relevant reference points.
Using the devices functionality a user will be guided through the process by answering relevant questions about the patient and their symptoms. In some cases the answer may not be entirely clear but developing the pathway as an app allows you to include additional information in the form of text, images and video to help clarify points and questions. In addition to this if there are other reference points that are relevant to the pathway, links can be built into these to help provide further explanation.

4. Test the app with local teams to check its effectiveness, sign off and launch the app and tell everyone about it.
As with any new tool, it’s important that you test it thoroughly before launching it for use by the whole of the department/organisation. Testing should involve making sure that each end-user can fully complete each specific task on the app that you set them. If they are unable to do so then you will be able to identify whether the app has a technical glitch or if the user journey is not clear and thus making it confusing for the end-user to complete the task. It’s also important to make sure that if the app is designed for use on multiple devices and operating systems, i.e. iPhone, Android, iPad, Blackberry, Microsoft etc, then make sure that you have users in your testing group that will be trialling the app on each of the devices and platforms that you will want the app to work on.

5. Track usage and improve the app where necessary
Even when the app is ‘live’ and in use it’s still important to capture data on its usage and give end-users the opportunity to submit feedback to highlight any glitches or possible areas for improvement. Your end-users can provide you with some useful insights into additional features and functionality that could help make the app even more useful and this can help to encourage more people to download it.

Medical app compliance

World’s first prescription only app

Take Two Pills Twice a Day – and An App

Without our mobile phones we would be lost, appointments would be missed, and our lives would fall apart.  We rely on smartphones to get us up and get us through the day but are we ready to rely on them for medical advice?  An innovative new app is due to launch later this year, as BlueStar’s prescription only app for smartphone becomes a trailblazer in its field.

Could this potentially be the start of something momentous, and poses the question – just how far away are we from being prescribed apps with our medication?

Do we even want to go down that route?  What are the pitfalls and the benefits?  Is introducing this remoteness and prescription by app to be welcomed or feared?  Will GP’s be comfortable prescribing an app with medication and how will a prescription only app be paid for? Furthermore, what restrictions will be placed on marketers with regards to promoting the app, will it fall under the ABPI code of practice as do prescription only medicines (POMs)? So, are we likely to see the buzzword POA (prescription only apps) being added to the pharma jargon dictionary?

WellDoc – a prescription only app

WellDoc - World's first prescription only appThe Blue Star app can be downloaded to tablet, computer or smartphone in the normal way but will only become interactive with a special prescription code issued by a pharmacy. This is the first healthcare app that needs a doctor’s prescription to work and it is being trialled in a small area of the US where it is already causing quite a stir, as several large US corporations have announced plans to incorporate the app into the health cover that they offer their employees.  The precise cost of the app is not yet known but speculation is that it is very likely to be some way over $100 per month.

This medical app has been put through its paces by the FDA in the USA and was approved for use in 2010.  The app has been designed as an aid for people with type 2 diabetes.  It prompts them to check blood sugar levels and gives them useful information about controlling fluctuations in glucose levels along with other advice to help them manage their condition. The prescription only app will offer encouragement and praise for regular blood sugar checking and might also issue helpful reminders to take medication with food, for instance.

Following in the wake of Nike’s FuelBand, an app that is designed to record health related performance, Blue Star’s app does not monitor a patient directly but rather provides a platform for them to use to record the information needed to best manage their condition.  The question is how will doctors receive this innovation?  Not having immediate control of their patient may not sit well, but BlueStar plan to calm any qualms by sending patients statistics to doctors who can then use the data to make adjustments to treatment.  Another potential stumbling block may be the perceived intrusion that might be resented by patients if no immediate improvement or benefit is seen. Only time will tell if the prescription only app is going to become mainstream.

University of Southampton Liver Disease App

University of Southampton Liver Traffic Light Calculator App

Genetic Digital has completed development of the University of Southampton Liver Traffic Light Calculator iPhone App.

University Hospital Southampton NHS Trust

University of Southampton Liver Traffic Light Calculator App

The live ‘traffic light’ calculator is a test for liver disease suitable for community use that could enhance assessment of liver risk and allow rational referral of more severe disease to specialist care. The algorithm used within this calculator only works with assays done by University of Southampton University Hospital Trust. It must NOT be used with individual test results from other hospitals.

Liver disease develops silently and presents late with end-stage disease; as a result, one-third of new admissions die within the first few months, and death rates have doubled in the last 15 years.

To learn more about the App and to download it for free visit the iTunes store